Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
449 studies found for:    PAH
Show Display Options
RSS Create an RSS feed from your search for:
PAH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
2 Active, not recruiting Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Nitric Oxide;   Other: Placebo
3 Unknown  Training With Whole Body Vibration Device in Patients With PAH
Condition: Pulmonary Artery Hypertension
Intervention: Device: Exercise Group Galileo PAH
4 Unknown  Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Conditions: Thalassemia Major;   Thalassemia Intermedia;   Pulmonary Arterial Hypertension
Intervention: Other: Physician standard-of-care according to ESC/ERS Guidelines
5 Completed PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PSA-Activated PSA-PAH1
6 Recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Conditions: Pulmonary Arterial Hypertension;   PAH
Intervention: Drug: Macitentan
7 Terminated
Has Results
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: treprostinil;   Device: Crono Five ambulatory pump
8 Recruiting BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Dietary Supplement: Beetroot juice
9 Recruiting Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
Condition: Life Change Events
Interventions: Procedure: Pulmonary Arterial Denervation (PADN);   Drug: sildenafil;   Drug: boston;   Drug: prostacyclin
10 Terminated FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Placebo;   Drug: FK506 level < 2 ng/ml;   Drug: FK506 level 2-3 ng/ml;   Drug: FK506 level 3-5 ng/ml
11 Recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
Intervention:
12 Completed Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Blood draw
13 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium
14 Terminated Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)
Conditions: Pulmonary Arterial Hypertension;   Obstructive Sleep Apnea
Intervention:
15 Recruiting Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
Condition: PAH
Intervention: Drug: oral treprostinil
16 Completed Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: inhaled prostacyclin;   Drug: prostacyclin;   Drug: subcutaneous and intravenous prostacyclin;   Drug: oral ERA;   Drug: oral PDE5 inhibitors
17 Completed Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
Condition: Pulmonary Arterial Hypertension
Intervention:
18 Completed Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil;   Drug: Sugar Pill
19 Recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
20 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years